Factors related to medical appointment attendance after childbirth among HIV-infected women in the Paris region

AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV

Volumn 19, Issue 3, 2007, Pages 346-354

  Lemly, D ^a,b   Mandelbrot, L ^a   Meier, F ^a   Firtion, G ^c   Matheron, S ^d   Jeantils, V ^e   Scott, T A ^a,b  

^a HÔPITAL LOUIS MOURIER   (France)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Institut Cochin   (France)

^d BICHAT HOSPITAL   (France)

^e HÔPITAL JEAN VERDIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ZIDOVUDINE;

ADULT; ARTICLE; CHILDBIRTH; DELIVERY; FEMALE; FOLLOW UP; FRANCE; HEALTH CARE PERSONNEL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERPERSONAL COMMUNICATION; MAJOR CLINICAL STUDY; MEDICAL EXAMINATION; MOTHER; MULTIVARIATE ANALYSIS; PREGNANCY; PRENATAL CARE; PRIORITY JOURNAL; PUERPERIUM;

ADULT; AMBULATORY CARE; ANTI-RETROVIRAL AGENTS; COHORT STUDIES; FEMALE; HIV INFECTIONS; HUMANS; PARIS; PATIENT COMPLIANCE; POSTNATAL CARE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RETROSPECTIVE STUDIES;

EID: 34147221591     PISSN: 09540121     EISSN: 13600451     Source Type: Journal    
DOI: 10.1080/00033790600658444     Document Type: Article

References (29)

1. Anderson, J., & Doyal, L. (2004). Women from Africa living with HIV in London: a descriptive study. AIDS Care, 16, 95-105.
2. Arici, C., Ripamonti, D., Maggiolo, F., et al. (2002). Factors associated with the failure of HIV-positive persons to return for scheduled medical visits. HIV Clinical Trials, 3, 52-57.
3. Bakken, S., Holzemer, W.L., Brown, M., et al. (2000). Relationships between perception of engagement with health care provider and demographic characteristics, health status, and adherence to therapeutic regimen in persons with HIV/AIDS. AIDS Patient Care and STDs, 14, 189-97.
4. Bungener, C., Marchand-Gonod, N., & Jouvent, R. (2000). African and European HIV-positive women: psychological and psychosocial differences. AIDS Care, 12, 541-48.
5. Catz, S.L., McClure, J.B., Jones, G.N., et al. (1999). Predictors of outpatient medical appointment attendance among persons with HIV. AIDS Care, 11, 361-73.
6. Centers for Disease Control and Prevention (2004) HIV/AIDS Surveillance Report, 15. Atlanta: US Department of Health and Human Services, Center for Disease Control and Prevention. Also available at: http://www.cdc.gov/hiv/stats/hasrlink.htm.
7. Centre Régional d'Information et de Prévention du Sida en Ile-de-France (CRIPS) (2001). Suivi de l'infection à VIH-SIDA en Ile-de-France. Bulletin de Santé, 1-8 December,.
8. Delfraissy, J.F. (2004). Prise en charge des personnes infectées par le VIH. Paris: Flammarion Médecine-Sciences.
9. Demas, P.A., Thea, D., Weedon, J., et al. (2005). Adherence to zidovudine for the prevention of perinatal transmission in HIV-infected pregnant women: the impact of social network factors, side effects, and perceived treatment efficacy. Women & Health, 42, 99-115.
10. Demas, P.A., Webber, M.P., Schoenbaum, E.E., et al. (2002). Maternal adherence to the zidovudine regimen for HIV-exposed infants to prevent HIV infection: a preliminary study. Pediatrics, 110, e35.
11. Demmer, C. (2003). Relationship with health care provider and adherence to HIV medications. Psychological Reports, 93, 494-96.
12. Goldman, D.P., et al. (2003). Insurance status of HIV-infected adults in the post-HAART era: evidence from the United States. Applied Health Economics and Health Policy, 2, 85-90.
13. Harrell, F.E. (2001). Regression Modeling Strategies with Applications to Linear Models, Logistic Regression, and Survival Analysis. New York: Springer.
14. Haynes, R.B. (1979). Determinants of adherence/ the disease and the mechanisms of treatment. In R.B. Haynes, D.W. Taylor, & D. Sackett (Eds.), Adherence in Health Care. Baltimore: John Hopkins Press.
15. Ickovics, J.R., Wilson, T.E., Royce, R.A., et al. (2002). Prenatal and postpartum zidovudine adherence among pregnant women with HIV: Results of a MEMS substudy from the Perinatal Guidelines Evaluation Project. Journal of Acquired Immune Deficiency Syndromes, 30, 311-15.
16. Israelski, D., Gore-Felton, C., Power, R., et al. (2001). Sociodemographic Characteristics Associated with Medical Appointment Adherence among HIV-Seropositive Patients Seeking Treatment in a County Outpatient Facility. Preventive Medicine, 33, 470-75.
17. Mandelbrot, L., Landreau-Mascaro, A., Rekacewicz, C., et al. (2001). Lamivudine-zidovudine combination for prevention of maternal-infant transmission of HIV-1. JAMA, 285, 2083-93.
18. Mayaux, M.J., Teglas, J.P., Blanche, S., et al. (2002). Characteristics of HIV-infected women who do not receive preventive antiretroviral therapy in the French Perinatal Cohort. Journal of Acquired Immune Deficiency Syndromes, 34, 338-43.
19. Mellins, C.A., Kang, E., Leu, C.S., Havens, J.F., et al. (2003). Longitudinal Study of Mental Health and Psychosocial Predictors of Medical Treatment Adherence in Mothers Living with HIV Disease. AIDS Patient Care and STDs, 17, 407-16.
20. Painter, T.M., Diaby, K.L., Matia, D.M., et al. (2004). Women's reasons for not participating in follow up visits before starting short course antiretroviral prophylaxis for prevention of mother to child transmission of HIV: qualitative interview study. British Medical Journal, 329, 543-47.
21. Perinatal HIV Guidelines Working Group. US Public Health Service Task Force Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV-1 Transmission in the United States. Department of Health and Human Services, 23 June, 2004. Available at: http://AIDSinfo.nih.gov.
22. R Development Core Team (2004). R: A language and environment for statistical computing. R Foundation for Statistical Computing. Vienna, Austria. Available at: http://www.R-project.org.
23. Schneider, J., Kaplan, S.H., et al. (2004). Better physician-patient relationships are associated with higher reported adherence to antiretroviral therapy in patients with HIV infection. Journal of General Internal Medicine, 19, 1096-103.
24. Turner, B.J., Newschaffer, C.J., Zhang, D., et al. (2000). Antiretroviral Use and Pharmacy-Based Measurement of Adherence in Postpartum HIV-Infected Women. Medical Care, 38, 911-25.
25. Vayssiere, C., Du Mazaubrun, C., & Breart, G. (1999). Human immunodeficiency virus screening among pregnant women in France: results from the 1995 National Perinatal Survey. American Journal of Obstetrics and Gynecology, 180, 564-70.
26. rd ICAAC, abstract H-859, Chicago 14-17 September.
27. Wood, S.A., Tobias, C., & McCree, J. (2004). Medication adherence for HIV positive women caring for children: in their own words. AIDS Care, 16, 909-13.
28. Yeni, P.G., Hammer, S.M., Carpenter, C.C., et al. (2002). Antiretroviral treatment for adult HIV infection in 2002: updated recommendations of the International AIDS Society-USA Panel. JAMA, 288, 222-35.
29. Zorilla, C.D., Santiago, L.E., Knubson, D., et al. (2003). Greater adherence to highly active antiretroviral therapy (HAART) between pregnant versus non-pregnant women living with HIV. Cellular and Molecular Biology, 49, 1187-92.